Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

A systems biology perspective on rational design of peptide vaccine against virus infections.

Chen J, Wang Y, Guo D, Shen B.

Curr Top Med Chem. 2012;12(12):1310-9. Review.

PMID:
22690678
2.

Virus-epitope vaccine design: informatic matching the HLA-I polymorphism to the virus genome.

Vider-Shalit T, Raffaeli S, Louzoun Y.

Mol Immunol. 2007 Feb;44(6):1253-61. Epub 2006 Aug 22.

PMID:
16930710
3.

Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.

Rosendahl Huber SK, Camps MG, Jacobi RH, Mouthaan J, van Dijken H, van Beek J, Ossendorp F, de Jonge J.

PLoS One. 2015 Jun 5;10(6):e0127969. doi: 10.1371/journal.pone.0127969. eCollection 2015.

4.

Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.

Volz A, Sutter G.

Adv Virus Res. 2017;97:187-243. doi: 10.1016/bs.aivir.2016.07.001. Epub 2016 Aug 1. Review.

PMID:
28057259
5.

Advances in antiviral vaccine development.

Graham BS.

Immunol Rev. 2013 Sep;255(1):230-42. doi: 10.1111/imr.12098. Review.

6.

Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.

WHO Writing Group, Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M, Zhang W.

Influenza Other Respir Viruses. 2012 Mar;6(2):142-52, e1-5. doi: 10.1111/j.1750-2659.2011.00277.x. Epub 2011 Aug 8.

7.

Design of synthetic peptidic constructs for the vaccine development against viral infections.

Haro I, Gómara MJ.

Curr Protein Pept Sci. 2004 Dec;5(6):425-33. Review.

PMID:
15581414
8.

Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflage.

He L, De Groot AS, Gutierrez AH, Martin WD, Moise L, Bailey-Kellogg C.

BMC Bioinformatics. 2014;15 Suppl 4:S1. doi: 10.1186/1471-2105-15-S4-S1. Epub 2014 Mar 19.

9.

Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses.

Sirskyj D, Diaz-Mitoma F, Golshani A, Kumar A, Azizi A.

Immunol Cell Biol. 2011 Jan;89(1):81-9. doi: 10.1038/icb.2010.65. Epub 2010 May 11. Review.

PMID:
20458336
10.

High-throughput sequencing and vaccine design.

Luciani F.

Rev Sci Tech. 2016 Apr;35(1):53-65. doi: 10.20506/rst.35.1.2417. Review.

PMID:
27217168
11.

From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.

Alam A, Ali S, Ahamad S, Malik MZ, Ishrat R.

Immunology. 2016 Dec;149(4):386-399. doi: 10.1111/imm.12656. Epub 2016 Sep 7.

12.

Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.

Ampofo WK, Azziz-Baumgartner E, Bashir U, Cox NJ, Fasce R, Giovanni M, Grohmann G, Huang S, Katz J, Mironenko A, Mokhtari-Azad T, Sasono PM, Rahman M, Sawanpanyalert P, Siqueira M, Waddell AL, Waiboci L, Wood J, Zhang W, Ziegler T; WHO Writing Group.

Vaccine. 2015 Aug 26;33(36):4368-82. doi: 10.1016/j.vaccine.2015.06.090. Epub 2015 Jul 3.

13.

Computer-aided vaccine designing approach against fish pathogens Edwardsiella tarda and Flavobacterium columnare using bioinformatics softwares.

Mahendran R, Jeyabaskar S, Sitharaman G, Michael RD, Paul AV.

Drug Des Devel Ther. 2016 May 23;10:1703-14. doi: 10.2147/DDDT.S95691. eCollection 2016.

14.

Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

Poland GA, Ovsyannikova IG, Kennedy RB, Haralambieva IH, Jacobson RM.

OMICS. 2011 Sep;15(9):625-36. doi: 10.1089/omi.2011.0032. Epub 2011 Jul 6. Review.

15.

Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach.

Oany AR, Emran AA, Jyoti TP.

Drug Des Devel Ther. 2014 Aug 21;8:1139-49. doi: 10.2147/DDDT.S67861. eCollection 2014.

16.

Enhancing the role of veterinary vaccines reducing zoonotic diseases of humans: linking systems biology with vaccine development.

Adams LG, Khare S, Lawhon SD, Rossetti CA, Lewin HA, Lipton MS, Turse JE, Wylie DC, Bai Y, Drake KL.

Vaccine. 2011 Sep 22;29(41):7197-206. doi: 10.1016/j.vaccine.2011.05.080. Epub 2011 Jun 7.

17.

The value of HIV protective epitope research for informed vaccine design against diverse viral pathogens.

Kramer VG, Byrareddy SN.

Expert Rev Vaccines. 2014 Aug;13(8):935-7. doi: 10.1586/14760584.2014.928597. Epub 2014 Jun 26.

18.

Progress in respiratory virus vaccine development.

Schmidt AC.

Semin Respir Crit Care Med. 2011 Aug;32(4):527-40. doi: 10.1055/s-0031-1283289. Epub 2011 Aug 19. Review.

19.

Novel vaccine strategies against emerging viruses.

García-Sastre A, Mena I.

Curr Opin Virol. 2013 Apr;3(2):210-6. doi: 10.1016/j.coviro.2013.02.001. Epub 2013 Mar 7. Review.

20.

A Brief Review of Computer-Assisted Approaches to Rational Design of Peptide Vaccines.

Nandy A, Basak SC.

Int J Mol Sci. 2016 May 4;17(5). pii: E666. doi: 10.3390/ijms17050666. Review.

Supplemental Content

Support Center